ANDA 40413, held by Able. Methocarbamol.
As of Nov 14, 2026, ANDA 40413 (Methocarbamol), held by Able, was first approved by FDA on Mar 17, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 17, 2003 | Original application | Approved | None posted |
| Methocarbamol500MG · tablet;oral | Methocarbamol | Discontinued |
| Methocarbamol750MG · tablet;oral | Methocarbamol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
